Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Anemia
•
Hematology
•
Benign Hematology
In a patient with cold agglutinin disease on observation, when do you suspect Waldenstrom macroglobulinemia?
Do you prefer following IgM level or M protein?
Related Questions
When would you treat mild anemia from low testosterone in an older male?
What experience have you had with familial clustering of polycythemia vera?
Do you consider prophylactically increasing eculizumab frequency for pregnant or postpartum PNH patients?
How do you decide between HSCT and immunosuppressive therapy for treating hepatitis associated aplastic anemia?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How do you decide between systemic antiangiogenic therapies for HHT?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How would you manage superficial thrombophlebitis of the great saphenous vein involving the knee and calf?
How do you approach second-line options for relapsed myeloma after front-line quadruplet therapy?